Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

OTC drugs get boost in FDA budget request

This article was originally published in The Tan Sheet

Executive Summary

The Obama administration's $457.8 million fiscal year 2010 budget request for FDA's human drugs activities includes $15.1 million for over-the-counter products, which would represent a 1.1 percent increase over the fiscal 2009 appropriation of $14.9 million, according to the Department of Health and Human Services justification of estimates for appropriations committees document. Among FDA's planned activities for fiscal 2010, it intends to make "significant progress" on five OTC drug monographs and act on 100 percent of all Rx-to-OTC switch applications within 10 months of receipt, the agency says in its performance appendix. An FDA spokesman was unable to break the OTC drug request number down into more specific activities

Related Content

Topics

UsernamePublicRestriction

Register

PS102926

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel